Daily News Podcast

Semaglutide plus SGLT2 inhibitors for type 2 diabetes

Publish date: March 14, 2019

 

A combination approach to type 2 diabetes that could improve glycemic control and increase weight loss. Also today, patients with HIV may have a greater risk of opioid overdose, why Eisenmeyer syndrome can be a minefield for unwary physicians, and heart attacks and strokes spike in the month after cancer diagnosis.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Mediterranean diet cut Parkinson’s risk
MDedge Endocrinology
A prescription for medicine’s gender inequality
MDedge Endocrinology
Parental leave inequities: Kirti Magudia and Thomas Ng, Part I
MDedge Endocrinology
Trump targets abortion by denying family planning funds
MDedge Endocrinology
Will having fewer primary care physicians shorten Americans’ lifespans?
MDedge Endocrinology
Cancer-battling breath, Zombie Bambi, and hops as health food
MDedge Endocrinology
Esketamine gets the green light for depression
MDedge Endocrinology
Ready for universal hepatitis C testing?
MDedge Endocrinology
Autism risk with in utero infections
MDedge Endocrinology
Aspirin and lower risk of COPD flare-up
MDedge Endocrinology